Urinary N-telopeptide: The New Diagnostic Test for Osteoporosis
Abstract Context Osteoporosis is a silent disease until it is complicated by trivial fall fractures. There is an increasing interest within the orthopaedic community in the noninvasive cost-effective measurement of the bone mineral density. Aims The aim of the study is to a...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Medical Publishers, Inc.
2019-01-01
|
Series: | The Surgery Journal |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1677483 |
id |
doaj-f659eb133d6a414e829ab3c2b6bbac2e |
---|---|
record_format |
Article |
spelling |
doaj-f659eb133d6a414e829ab3c2b6bbac2e2021-04-02T13:45:40ZengThieme Medical Publishers, Inc.The Surgery Journal2378-51282378-51362019-01-010501e1e410.1055/s-0038-1677483Urinary N-telopeptide: The New Diagnostic Test for OsteoporosisGanesan Ram Ganesan0Phagal Varthi Vijayaraghavan1Department of Orthopaedics, Sri Ramachandra University, Chennai, Tamil Nadu, IndiaDepartment of Orthopaedics, Sri Ramachandra University, Chennai, Tamil Nadu, IndiaAbstract Context Osteoporosis is a silent disease until it is complicated by trivial fall fractures. There is an increasing interest within the orthopaedic community in the noninvasive cost-effective measurement of the bone mineral density. Aims The aim of the study is to assess whether urinary N-telopeptide level can be a new diagnostic tool in diagnosing osteoporosis. Methods and Material This prospective study was done at Sri Ramachandra Medical Centre (SRMC) hospital from October 2015 to October 2017. The study was conducted among patients who comes to SRMC as inpatient or outpatient with suspected osteoporosis and underwent dual-energy X-ray absorptiometry (DXA) scan and urinary N-telopeptide. The inclusion criteria were women aged 65 or older, women aged less than 65 with risk factors, younger postmenopausal women with one or more risk factors, men aged 70 or older, men less than 70 with risk factors, and any above group patients who comes within 24 hours following trivial fall fractures. The exclusion criteria were pathological fracture, history of any illness affecting bone metabolism. The results from DXA scan were taken as gold standard against urinary N-telopeptide. Then the patients were divided into two groups control and study. The control group contains patients who had normal DXA, while study group contains patients having either osteopenia or osteoporosis. Based on our inclusion and exclusion criteria, 110 persons were included in the study. We had 60 study and 50 controls patients. We had 88 females and 22 males. The results obtained were statistically analyzed. Statistical Analysis Used The collected data were analyzed with IBM SPSS statistics software 23.0 version. To describe about the data descriptive statistics frequency analysis, percentage analysis was used for categorical variables and the mean and standard deviation were used for continuous variables. To find the significant difference between the bivariate samples in independent groups, the unpaired sample t-test was used. To find the significance in categorical data, chi-square test was used. In both the earlier statistical tools, the probability value of 0.05 is considered as significant level. Results In our study, we had 18.2% osteopenic and 36.4% osteoporotic patients. The mean value of urinary N-telopeptide in control was 49.8 and in case was 182.5. The standard deviation of urinary N-telopeptide value in case was 159.9. Conclusion Urinary N-telopeptide can give reproducible results and be able to assist in the evaluation of the quantity as well as the quality and be a good judge of someone's risk of fracture. Hence, urinary N-telopeptide can be used as a diagnostic tool for diagnosing osteoporosis.http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1677483osteoporosisdxa scanosteopeniatelopeptidefracture |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ganesan Ram Ganesan Phagal Varthi Vijayaraghavan |
spellingShingle |
Ganesan Ram Ganesan Phagal Varthi Vijayaraghavan Urinary N-telopeptide: The New Diagnostic Test for Osteoporosis The Surgery Journal osteoporosis dxa scan osteopenia telopeptide fracture |
author_facet |
Ganesan Ram Ganesan Phagal Varthi Vijayaraghavan |
author_sort |
Ganesan Ram Ganesan |
title |
Urinary N-telopeptide: The New Diagnostic Test for Osteoporosis |
title_short |
Urinary N-telopeptide: The New Diagnostic Test for Osteoporosis |
title_full |
Urinary N-telopeptide: The New Diagnostic Test for Osteoporosis |
title_fullStr |
Urinary N-telopeptide: The New Diagnostic Test for Osteoporosis |
title_full_unstemmed |
Urinary N-telopeptide: The New Diagnostic Test for Osteoporosis |
title_sort |
urinary n-telopeptide: the new diagnostic test for osteoporosis |
publisher |
Thieme Medical Publishers, Inc. |
series |
The Surgery Journal |
issn |
2378-5128 2378-5136 |
publishDate |
2019-01-01 |
description |
Abstract
Context Osteoporosis is a silent disease until it is complicated by trivial fall fractures. There is an increasing interest within the orthopaedic community in the noninvasive cost-effective measurement of the bone mineral density.
Aims The aim of the study is to assess whether urinary N-telopeptide level can be a new diagnostic tool in diagnosing osteoporosis.
Methods and Material This prospective study was done at Sri Ramachandra Medical Centre (SRMC) hospital from October 2015 to October 2017. The study was conducted among patients who comes to SRMC as inpatient or outpatient with suspected osteoporosis and underwent dual-energy X-ray absorptiometry (DXA) scan and urinary N-telopeptide. The inclusion criteria were women aged 65 or older, women aged less than 65 with risk factors, younger postmenopausal women with one or more risk factors, men aged 70 or older, men less than 70 with risk factors, and any above group patients who comes within 24 hours following trivial fall fractures. The exclusion criteria were pathological fracture, history of any illness affecting bone metabolism. The results from DXA scan were taken as gold standard against urinary N-telopeptide. Then the patients were divided into two groups control and study. The control group contains patients who had normal DXA, while study group contains patients having either osteopenia or osteoporosis. Based on our inclusion and exclusion criteria, 110 persons were included in the study. We had 60 study and 50 controls patients. We had 88 females and 22 males. The results obtained were statistically analyzed.
Statistical Analysis Used The collected data were analyzed with IBM SPSS statistics software 23.0 version. To describe about the data descriptive statistics frequency analysis, percentage analysis was used for categorical variables and the mean and standard deviation were used for continuous variables. To find the significant difference between the bivariate samples in independent groups, the unpaired sample t-test was used. To find the significance in categorical data, chi-square test was used. In both the earlier statistical tools, the probability value of 0.05 is considered as significant level.
Results In our study, we had 18.2% osteopenic and 36.4% osteoporotic patients. The mean value of urinary N-telopeptide in control was 49.8 and in case was 182.5. The standard deviation of urinary N-telopeptide value in case was 159.9.
Conclusion Urinary N-telopeptide can give reproducible results and be able to assist in the evaluation of the quantity as well as the quality and be a good judge of someone's risk of fracture. Hence, urinary N-telopeptide can be used as a diagnostic tool for diagnosing osteoporosis. |
topic |
osteoporosis dxa scan osteopenia telopeptide fracture |
url |
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1677483 |
work_keys_str_mv |
AT ganesanramganesan urinaryntelopeptidethenewdiagnostictestforosteoporosis AT phagalvarthivijayaraghavan urinaryntelopeptidethenewdiagnostictestforosteoporosis |
_version_ |
1721564104508833792 |